期刊文献+

肝硬化对单个小肝细胞癌切除术后复发和患者长期生存的影响 被引量:9

Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma
原文传递
导出
摘要 目的比较肝硬化患者和非肝硬化患者的单个小肝细胞癌(长径≤5cm)手术切除疗效,探讨肝硬化对单个小肝细胞癌切除术后复发和患者长期生存的影响。方法采用回顾性研究方法,将2001年4月至2009年10月在我院肝脏外科中心接受肝切除术的单个小肝细胞癌患者共256例分为非肝硬化组(44例)和肝硬化组(212例),比较两组患者的无瘤生存率和总体生存率。男性227例,女性29例;年龄14~79岁,中位年龄49岁。224例(87.5%)患者合并乙型肝炎,241例(94.1%)患者术前肝功能为ChildA级。采用单因素和多因素分析探讨单个小肝细胞癌患者肝切除术后的预后因素。结果非肝硬化组患者的1、3、5年无瘤生存率和总体生存率分别为93.0%、85.3%、68.5%和100%、92.5%、92.5%,肝硬化组患者的1、3、5年无瘤生存率和总体生存率分别为81.1%、58.6%、45.0%和93.8%、78.7%、67.8%。非肝硬化组患者的无瘤生存率和总体生存率优于肝硬化组(χ^2=8.756,P=0.003;χ^2=8.603,P=0.003)。血管侵犯、肿瘤中低分化、无肿瘤包膜和肝硬化是影响单个小肝细胞癌患者肝切除术后复发的独立危险因素,亦是影响患者术后长期生存的独立危险因素。结论除血管侵犯、肿瘤中低分化、无肿瘤包膜等肿瘤生物学因素外,肝硬化亦是影响单个小肝细胞癌切除术后患者长期生存的重要不良预后因素。肝硬化患者肝切除术后的长期疗效劣于非肝硬化患者。 Objectives To compare the outcomes after liver resection for a single small hepatocellular carcinoma (HCC) (~〈5 cm) between non-cirrhotic patients and cirrhotic patients, and to explore the influence of liver cirrhosis on recurrence and overall survival after liver resection in patients with a single small HCC. Methods A consecutive series of 256 patients with a single small HCC undergoing liver resection from April 2001 to October 2009 was retrospectively reviewed. Among the 256 patients, 227 patients were male, and 29 were female. The medium age was 49 years ( ranged, 14-79 years ) ; 224 (87.5%) patients were positive for hepatitis B surface antigen, 241 (94.1%) patients were with preoperative liver function of Child-Pugh grade A. The entire cohort were divided into non-cirrhosis group (n = 44) and cirrhosis group (n = 212). Univariate analysis and then multivariate analysis were performed to determine the prognostic factors of recurrence and overall survival after liver resection for all patients. Results The 1-, 3-, 5-year recurrence-free survival rates after liver resection were 93.0% , 85.3% , and 68.5%, respectively, in non-cirrhosis group, while 81.1%, 58.6%, and 45.0%, respectively, in cirrhosis group. The 1-, 3-, 5-year overall survival rates after liver resection were 100% , 92. 5% , and 92. 5% , respectively, in non-cirrhosis group, while 93.8% , 78.7% , and 67.8% , respectively, in cirrhosis group. Both the recurrence-free survival and overall survival of non-cirrhosis group were significantly better than those of cirrhosis group ( χ^2 = 8. 756, P = 0. 003 ; χ^2 = 8. 603, P = 0. 003 ).Cirrhosis, absence of tumor capsule, presence of mierovascular invasion and moderate/poor tumor differentiation were the independent adverse prognostic factors for recurrence-free survival and overall survival in patients with a single small HCC after liver resection. Conclusions Cirrhosis is an important adverse prognostic factor for long-term survival in patients with a single small HCC after liver resection. Liver resection resulted in much worse survival for cirrhotic patients compared to non-cirrhotic patients.
出处 《中华外科杂志》 CAS CSCD 北大核心 2012年第10期865-869,共5页 Chinese Journal of Surgery
基金 基金项目:新世纪人才支持计划基金资助项目(NCET-04-0701) 国家自然科学基金资助项目(81172293,30972901)
关键词 肝细胞 肝肿瘤 肝硬化 肝切除术 肿瘤复发 局部 Carcinoma, hepatocellular Liver neoplasms Liver cirrhosis Hepatectomy Neoplasm recurrence, local
  • 相关文献

参考文献3

二级参考文献53

  • 1孙惠川,汤敏,钦伦秀,王鲁,叶青海,任宁,樊嘉,曾蒙苏,汤钊猷.用余肝体积预测半肝切除耐受性的安全标准[J].中华肝胆外科杂志,2006,12(6):366-369. 被引量:24
  • 2吴志全,樊嘉,周俭,邱双健,汤钊猷.逆行法肝切除术在肝癌手术中的应用[J].中华消化外科杂志,2007,6(3):191-193. 被引量:8
  • 3樊嘉,周俭,吴志全,邱双健,王征,余耀,史颖弘,汤钊猷.中央型肝癌的手术切除[J].中华消化外科杂志,2007,6(1):8-12. 被引量:19
  • 4Makuuchi M, Sano K. The surgical approach to HCC : our progress and results in Japan. Liver Transpl,2004,10 : S46-S52.
  • 5Fan J,Wu ZQ, Tang ZY, et al. Complete resection of the eaudate lobe of the liver with tumor: technique and experience. Hepatogastroenterology,2001,48 : 808-811.
  • 6Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis, 2005,25 : 181-200.
  • 7Zhou XD,Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer,2001,91 : 1479-1486.
  • 8Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for hepatocellular carcinoma on cirrhosis. Ann Surg, 2003,237 : 536- 543.
  • 9Sun HC, Tang ZY, Wang L, et al. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol, 2006,132:458-465.
  • 10Takayama T, Sekine T, Makuuchi M, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma : a randomized trial. Lancet, 2000, 356 (9232) :802-807.

共引文献90

同被引文献64

  • 1徐畅,程月娥,张平.全肝血流阻断肝脏部分切除术的手术配合[J].中华护理杂志,2004,39(5):369-370. 被引量:16
  • 2陈孝平,吴在德,裘法祖.肝癌切除联合脾切除治疗肝癌合并肝硬化、脾功能亢进[J].中华外科杂志,2005,43(7):442-446. 被引量:63
  • 3Chen XP,Huang ZY. Surgicat treatment of hepatocellular car-cinoma in China : surgical techniques, indications ,and outcomes[J]_ Langenbeeks Arch Surg,2005,390:259 - 265.
  • 4Torzilli G, Donado M,Marconi M,et al. Hepqtectomy for stageB and hepatoecllular carcinoma in the Barcelona Cline LiverCareer Glassifiication [ J ]; Arch Surg,2008, 3 (11) : 691 -694.
  • 5Qin Q, Wang LP,Li H,et al. Efficacy and Safety of RightHemihepatectomy Through the Right RetrohepaticTunnel[J].Cell Biochem Biophys,2012,62( 1) : 113 - 118.
  • 6Agnello F, Ronot M,Valla DC,et al. High-b-value diffu- sion-weighted MR imaging of benign hepatocellular le- sions:quantitative and qualitative analysis[J]. Radiology, 2012,262(2):511-519.
  • 7Purysko AS,Remer EM, Coppa CP,et al. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MR/ [J]. AJR Am J Roentgenol,2012,198(1): 115-123.
  • 8Grieser C, Steffen IG, Seehofer D, et al. Histopathologi- cally confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics[J]. Magn Reson Imaging, 2013,31 (5) :755-760.
  • 9Cristiano A, Dietrich A, Spina JC, et al. Focal nodular hy- perplasia and hepatic adenoma:current diagnosis and management H1. Uodates Surz. 2014.66(1): 9-21.
  • 10Yu Y,Lin X,Chen K,et al. Hepatocellular carcinoma and focal nodular hyperplasia of the liver:differentiation with CT spectral imaging[J]. Eur Radiol,2013,23(6): 1660-1668.

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部